Approach to anti-corruption

Takeda has established a framework of global policies on anti-corruption and is working to strengthen compliance.

Takeda is committed to observing the laws of each country, as well as applying high ethical and moral standards based on Takeda-ism with a priority on ensuring the health and safety of people all over the world.

Global Policies for Anti-Corruption

Takeda Global Code of Conduct

Compliance standards to which executives and employees in each Takeda company should adhere.

Takeda Anti-Corruption Global Policy

Detailed policy on "Anti-corruption/Anti-bribery" provided in Takeda Global Code of Conduct.

Global Investigations Policy

Outlines the process for handling investigations within Takeda.

Global Policy on Interactions withPatient Organizations and Patients

Establishes Takeda's compliance standards with respect to interactions with Patient Organizations, Patients and Caregivers to ensure that all such interactions comply with applicable Laws, regulations, industry codes and Takeda's applicable global standards.

Global Policy on Interactions with Health-care Professionals and Healthcare Entities(Scheduled to take effect in January 2017)

Establishes Takeda's compliance standards with respect to interactions with HCPs and HCEs to ensure that all such interactions comply with applicable Laws, regulations, industry codes and Takeda's applicable global standards.

Global Policy on Interactions with Government Officials and Government Entities(Scheduled to take effect in January 2017)

Establishes Takeda's compliance standards with respect to interactions with Government Officials (GOs) and Government Entities (GEs) to ensure that all such interactions comply with applicable Laws, regulations, industry codes and Takeda's applicable global standards.

KEY FIGURES

FUTURE OUTLOOK

Issues and Initiatives Going Forward

In order to provide guidance to ensure the policies are followed and to implement them effectively in line with the situation in each country, we are continually developing individual standard operating procedures for each country and region, which provide detailed guidance on acceptable conduct of specific business activities. Starting in January 2015, we implemented a comprehensive monitoring program to evaluate adherence with our policies and procedures in the conduct of our high risk business activities. Going forward, we will take even further measures to ensure rigorous compliance, promoting our compliance-related risk assessment programs to ensure we continue to build a best-in-class sustainable company that puts the patient at the center.